Post-Trade Analysis: Privia Health Group Inc (PRVA) Climbs 4.16, Closing at 18.80

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

After finishing at $18.05 in the prior trading day, Privia Health Group Inc (NASDAQ: PRVA) closed at $18.80, up 4.16%. In other words, the price has increased by $4.16 from its previous closing price. On the day, 0.85 million shares were traded. PRVA stock price reached its highest trading level at $19.02 during the session, while it also had its lowest trading level at $17.85.

Ratios:

Our goal is to gain a better understanding of PRVA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.63. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on April 22, 2024, initiated with a Buy rating and assigned the stock a target price of $25.

On March 06, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $22.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when Mountcastle David sold 3,933 shares for $17.77 per share. The transaction valued at 69,889 led to the insider holds 262,279 shares of the business.

Sullivan William M sold 400 shares of PRVA for $9,208 on Mar 11 ’24. The Director now owns 5,445,018 shares after completing the transaction at $23.02 per share. On Mar 08 ’24, another insider, Sullivan William M, who serves as the Director of the company, sold 7,115 shares for $23.03 each. As a result, the insider received 163,858 and left with 5,445,418 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2230732800 and an Enterprise Value of 1804897280. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 101.51, and their Forward P/E ratio for the next fiscal year is 56.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.34 while its Price-to-Book (P/B) ratio in mrq is 3.96. Its current Enterprise Value per Revenue stands at 1.089 whereas that against EBITDA is 66.4.

Stock Price History:

Over the past 52 weeks, PRVA has reached a high of $30.15, while it has fallen to a 52-week low of $17.54. The 50-Day Moving Average of the stock is -6.30%, while the 200-Day Moving Average is calculated to be -16.76%.

Shares Statistics:

The stock has traded on average 983.01K shares per day over the past 3-months and 861330 shares per day over the last 10 days, according to various share statistics. A total of 118.22M shares are outstanding, with a floating share count of 101.89M. Insiders hold about 14.06% of the company’s shares, while institutions hold 95.87% stake in the company. Shares short for PRVA as of 1711584000 were 6704751 with a Short Ratio of 6.82, compared to 1709164800 on 7572114. Therefore, it implies a Short% of Shares Outstanding of 6704751 and a Short% of Float of 9.120000000000001.

Most Popular

[the_ad id="945"]